期刊
JOURNAL OF CELL SCIENCE
卷 128, 期 14, 页码 2520-2528出版社
COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/jcs.170233
关键词
Amyloid precursor protein; Multivesicular body; Alzheimer's disease; ESCRT
类别
资金
- Alzheimer's Society
- Wellcome Trust
- Swedish Research Council
- MultiPark
- Alzheimer's Society [115] Funding Source: researchfish
Intracellular amyloid-beta (A beta) accumulation is a key feature of early Alzheimer's disease and precedes the appearance of A beta in extracellular plaques. A beta is generated through proteolytic processing of amyloid precursor protein (APP), but the intracellular site of A beta production is unclear. APP has been localized to multivesicular bodies (MVBs) where sorting of APP onto intraluminal vesicles (ILVs) could promote amyloidogenic processing, or reduce A beta production or accumulation by sorting APP and processing products to lysosomes for degradation. Here, we show that APP localizes to the ILVs of a subset of MVBs that also traffic EGF receptor (EGFR), and that it is delivered to lysosomes for degradation. Depletion of the endosomal sorting complexes required for transport (ESCRT) components, Hrs (also known as Hgs) or Tsg101, inhibited targeting of APP to ILVs and the subsequent delivery to lysosomes, and led to increased intracellular A beta accumulation. This was accompanied by dramatically decreased A beta secretion. Thus, the early ESCRT machinery has a dual role in limiting intracellular A beta accumulation through targeting of APP and processing products to the lysosome for degradation, and promoting A beta secretion.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据